Hint mode is switched on Switch off

REGENXBIO, ordinary share
RGNX, US75901B1070

Add a stock to WL
Choose all Reset all
REGENXBIO, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    REGENXBIO Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RGNX
  • Placement
    17.09.2015
  • Lock up period
    180
  • Number of papers
    6,300,000
  • Volume of raised funds
    138.6 mln USD
  • Final placement price
    22 USD
  • Price change since placement date
    -72.14%
  • By capitalization
    557.72 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RGNX
  • Placement
    23.03.2017
  • Lock up period
    180
  • Number of papers
    3,700,000
  • Volume of raised funds
    75.85 mln USD
  • Placement share
    12.26%
  • Final placement price
    20.5 USD
  • Price change since placement date
    -70.1%
  • By capitalization
    618.62 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RGNX
  • Placement
    10.08.2018
  • Lock up period
    180
  • Number of papers
    2,700,000
  • Volume of raised funds
    175.5 mln USD
  • Placement share
    7.72%
  • Final placement price
    65 USD
  • Price change since placement date
    -90.57%
  • By capitalization
    2,273.36 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

29/05/2026 REGENXBIO: Submission Of Matters To A Vote Of Security Holders, Other Events
14/05/2026 Regenxbio Q1 2026 Loss: Gene Therapy Progress Amid Financial Woes
18/03/2026 REGENXBIO: Entry Into A Material Definitive Agreement
07/02/2026 REGENXBIO: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
18/12/2025 REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference
All organization news

Holders

Industry Leaders

Registration is required to get access.